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SUMMARY
It has been suggested that the nicotinic acid provocation test is useful in the
diagnosis of Gilbert's syndrome. We compared the response to intravenous
nicotinic acid ofpatients with Gilbert's syndrome and with chronic liver disease.
There was no significant difference in the mean rise in unconjugated serum
bilirubin between the two groups. A sensitivity of 70% and specificity of 60%
were obtained. All of 5 patients with chronic liver disease and a raised fasting
unconjugated serum bilirubin had positive tests. We suggest that the nicotinic
acid test ispositive in unconjugated hyperbilirubinaemia regardless ofcause. It is
ofno value in differentiating Gilbert's syndrome from liver disease.
INTRODUCTION
Gilbert's syndrome is characterised by mild unconjugated hyperbilirubinaemia
increased by stress or fasting, in the absence of significant haemolysis or liver
disease. The differentiation of this benign condition from chronic liver disease
can be difficult without liver biopsy. The administration of nicotinic acid
intravenously produces a rise in serum unconjugated bilirubin which is greater
and more sustained in patients with Gilbert's syndrome than in normal controls,
and it has been suggested that nicotinic acid provocation is a useful diagnostic
test.' However, evidence that this test differentiates Gilbert's syndrome and liver
disease is lacking. We have compared the effects of nicotinic acid provocation on
patients with Gilbert's syndrome and with chronic liver disease.
PATIENTS AND METHODS
Westudied 15 patients with biopsy -proved chronic liver disease (10 with hepatitis
B surface antigen (HBsAg) negative chronic active hepatitis, 3 with alcoholic
hepatitis and 2 with cirrhosis), and 20 patients with Gilbert's syndrome which was
diagnosed onthefollowing criteria: intermittentorsustained unconjugated hyper -
bilirubinaemia for more than six months, normal serum liver enzyme activities
and no evidence of significant haemolysis (normal haemoglobin concentration,
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reticulocyte count, serum lactate dehydrogenase, plasma haemoglobin and
haptoglobin, and negative Coombs' test). Serum total and direct (conjugated)
bilirubin concentrations wereassayed using modifiedJendrassik-Groftechniques
(diazotised sulphanilic acid -based methods) and unconjugated bilirubin concen-
trations calculated from the difference (normal total and unconjugated bilirubin
concentrations < 18 pmol/l).
Informed consent was obtained from all patients and the nicotinic acid test was
performed asdescribed.1 Afteran overnight fast, patients received fifty milligrams
of nicotinic acid by slow intravenous injection. Blood samples were taken for
total and conjugated serum bilirubin assay at 30 minute intervals over three
hours. A positive result has been defined as a rise of greater than 17 pmol/l in
unconjugated bilirubin during the test.2
RESULTS
The figure shows the rise in unconjugated bilirubin three hours after adminis-
tration of nicotinic acid for each patient. The mean rise in patients with Gilbert's
syndrome was 21-55 ( ± 9-43) pmol/l (range 3-46) compared with 17-3
( ± 18-9) pmol/l (range 0-77) in those with liver diease: this difference was not
statistically significant.
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Figure. Rise in unconjugated bilirubin (pmol/l) 3 hours after administration of nicotinic acid.
(Positive test-rise greater than 17 pmol/I).
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A positive result, (a rise in unconjugated bilirubin of greater than 17 pmol/l),
was obtained in 14 of 20 patients with Gilbert's syndrome and in 6 of 15 with
chronic liver disease: the sensitivity of the test for Gilbert's disease was thus
70% and the specificity was 60%. Five patients, although previously diagnosed
as having Gilbert's syndrome, had a normal fasting unconjugated serum bilirubin
(.< 18 pmol/l) immediately before receiving nicotinic acid. Of these, three had
a negative test. All five patients with chronic liver disease and a raised uncon-
jugated fasting bilirubin had a positive test (range 19-77 pmol/l: mean 35).
Of20patientsintotal whohadaraised unconjugated fasting bilirubin, irrespective
ofdiagnosis, 18 hadapositive test, compared with 3 ofthe 15 remaining patients:
thus, the sensitivityofthe nicotinic acid test forunconjugated hyperbilirubinaemia
was 90% and specificity was 80%.
DISCUSSION
Mattei3 firstobserved thatserum unconjugated bilirubin risesaftertheintravenous
injection of nicotinic acid. The mechanism is unclear but alterations in the
erythrocyte membrane may occur making red cells more susceptible to splenic
haemolysis. The rise in bilirubin is abolished after splenectomy.4 Fromke and
Miller5 reported that serum unconjugated bilirubin rose characteristically three-
fold 120 minutes after the injection of nicotinic acid in patients with Gilbert's
syndrome compared with a twofold peak after 90 minutes in normal controls.
Davidson et all compared the rise in bilirubin in 16 patients with Gilbert's
syndrome and six normal controls. Levels in the control patients reached a
plateauat 90 minutes: incontrast, peak values fortheGilbert'ssyndrome patients
were higher and occurred later at 180 minutes. The mean increase in bilirubin at
180 minutes was significantly higher in the patients with Gilbert's syndrome than
in controls (23-3 ± 8 9 pmol/l v. 6 5 ± 4'8 pmol/l: p < 0.001). The authors
concluded that a single measurement of plasma bilirubin 180 minutes after the
administration of nicotinic acid could distinguish patients with Gilbert's syndrome
from normal subjects. Yet data for patients with liver disease are scanty. Fromke
and Miller5 described 2 patients with primary biliary cirrhosis and raised fasting
total serum bilirubin levels whohad response curvestypicalofGilbert'ssyndrome.
Ohkubo et al2 compared the rise in bilirubin following intravenous nicotinic acid
in patients with Gilbert's syndrome and with chronic hepatitis. They concluded
that a rise in unconjugated bilirubin of more than 17 pmol/l was "highly
suggestive" of Gilbert's disease, but the initial fasting bilirubin levels in patients
with liver disease were not stated.
In our study, the nicotinic acid test failed to discriminate between patients with
Gilbert's syndrome and those with a raised fasting unconjugated hyperbilirubin-
aemia due to chronic liver disease. All five patients with chronic liver disease
and a raised fasting unconjugated bilirubin had a positive test. We suggest that
an exaggerated response to nicotinic acid occurs in patients with a raised
unconjugated bilirubin regardless of cause. This is supported by the finding that
the response in patients with hyperbilirubinaemia due to haemolytic anaemia
does not differ significantly from that of Gilbert's syndrome.2 The nicotinic acid
provocation test is thus unreliable for the diagnosis of Gilbert's syndrome. We
agree with the suggestion6 that the diagnosis may be made, without the need for
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invasive tests, in patients with unconjugated hyperbilirubinaemia after careful
history, examination, blood tests to exclude haemolysis and liver disease and
12-18 month follow-up.
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